Recombinant Human Growth Hormone Market Report 2025 (Global Edition)

Global Recombinant Human Growth Hormone Market Report 2025 Market Size Split by Application (Growth Hormone Deficiency (GHD), Turner Syndrome, Chronic Renal Insufficiency, Prader Willi Syndrome, Small...

Recombinant Human Growth Hormone Market Report Description

We have various report editions of Recombinant Human Growth Hormone Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Recombinant Human Growth Hormone Market Insights Video

Competitive Landscape of the Recombinant Human Growth Hormone Market

The competitive landscape of the recombinant human growth hormone market is characterized by a range of players competing to gain market share through product innovation, strategic partnerships, and aggressive marketing efforts. Key players in the market include established electronics manufacturers, specialized recombinant human growth hormone companies, and emerging start-ups aiming to disrupt the market with innovative solutions.

May 2023: Novo Nordisk increased its presence in the human growth hormone therapy market with a positive statement from the European Medicines Agency advising once-weekly Sogroya for children aged three and above. This therapy addresses growth hormone deficiency and development failure in adolescents. This positions Sogroya as profitable replacement therapy, signaling a significant stride in Novo Nordisk's strategic foothold. (Source: https://www.novonordisk-us.com/media/news-archive/news-details.html?id=166098)

Top Companies Market Share in Recombinant Human Growth Hormone Industry: (In no particular order of Rank)

• Novo Nordisk A/S
• Eli Lilly and Company
• Pfizer
• Inc
• Sandoz International GmbH (Novartis AG)
• Genentech
• Inc. (Roche)
• Merck KGaA
• Ferring Pharmaceuticals
• Ipsen
• Teva Pharmaceutical Industries
• Ltd.
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Recombinant Human Growth Hormone Market

Which Region Dominates the Recombinant Human Growth Hormone Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024. It accounted for around 40% of the global revenue due to the region's rising prevalence of growth disorders, increased healthcare expenditure, and advancements in biotechnology. Enhanced awareness of growth hormone therapies and supportive regulatory frameworks also contribute to market growth.

Which Region is Expanding at the Fastest CAGR?

Asia Pacific stands out as the fastest-growing region in the recombinant human growth hormone market due to the region's rising prevalence of growth disorders, increasing healthcare awareness, and expanding healthcare infrastructure. Enhanced access to advanced treatments, growing demand for anti-aging therapies, and improving economic conditions also contribute to market growth, alongside rising investment in biotechnology and pharmaceuticals.

The current report Scope analyzes Recombinant Human Growth Hormone Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (Nigeria, South Africa, Rest of Africa)

The above graph is for illustrative purposes only.

North America Recombinant Human Growth Hormone Market Analysis

According to Cognitive Market Research, the global recombinant human growth hormone market size was estimated at USD 6125.6 Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD 2450.24 million in 2024 and will grow at a compound annual growth rate (CAGR) of 2.7% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the recombinant human growth hormone market with a market size of USD 1933.24 million in 2024 and is projected to grow at a CAGR of 2.5% during the forecast period. The nation's advancements in military technology.
• The Canada recombinant human growth hormone market had a market share of USD 294.03 million in 2024 and is projected to grow at a CAGR of 3.5% during the forecast period. Canada's strict government food safety rules in developing nations.
• The Mexico recombinant human growth hormone market is projected to witness growth at a CAGR of 3.2% during the forecast period, with a market size of USD 222.97 million in 2024.

Europe Recombinant Human Growth Hormone Market Analysis

According to Cognitive Market Research, the global recombinant human growth hormone market size was estimated at USD 6125.6 Million, out of which Europe held the market of more than 30% of the global revenue with a market size of USD 1837.68 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.0% from 2024 to 2031.

• The United Kingdom recombinant human growth hormone market had a market share of USD 308.73 million in 2024 and is projected to grow at a CAGR of 3.8% during the forecast period. In the UK, recombinant human growth hormone sales witness an upswing due to the nation's rising demand for this technology.
• The France recombinant human growth hormone market is projected to witness growth at a CAGR of 2.2% during the forecast period, with a market size of USD 169.07 million in 2024.
• According to Cognitive Market Research, the German recombinant human growth hormone market size was valued at USD 363.86 million in 2024 and is projected to grow at a CAGR of 3.2% during the forecast period. In Germany, recombinant human growth hormone surged due to the presence of major market players.
• The Italy recombinant human growth hormone market is projected to witness growth at a CAGR of 2.4% during the forecast period, with a market size of USD 158.04 million in 2024.
• The Russia recombinant human growth hormone market is projected to witness growth at a CAGR of 2.0% during the forecast period, with a market size of USD 284.84 million in 2024.
• The Spain recombinant human growth hormone market is projected to witness growth at a CAGR of 2.1% during the forecast period with a market size of USD 150.69 million in 2024
• The Luxembourg recombinant human growth hormone market is projected to witness growth at a CAGR of 3.1% during the forecast period, with a market size of USD 56.97 million in 2024.
• The Portugal recombinant human growth hormone market is projected to witness growth at a CAGR of 2.8% during the forecast period, with a market size of USD 38.59 million in 2024.
• The Greece recombinant human growth hormone market is projected to witness growth at a CAGR of 3.3% during the forecast period, with a market size of USD 22.05 million in 2024.
• Rest of Europe's recombinant human growth hormone market is projected to witness growth at a CAGR of 1.7% during the forecast period, with a market size of USD 284.84 million in 2024.

Asia Pacific Recombinant Human Growth Hormone Market Analysis

According to Cognitive Market Research, the global recombinant human growth hormone market size was estimated at USD 6125.6 Million, out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 1408.89 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2031.

• According to Cognitive Market Research, the China recombinant human growth hormone market size was valued at USD 634.00 million in 2024 and is projected to grow at a CAGR of 6.0% during the forecast period. Recombinant human growth hormone surged in China due to the adoption of various technologies.
• The Japan recombinant human growth hormone market is projected to witness growth at a CAGR of 5.0% during the forecast period, with a market size of USD 194.43 million in 2024.
• The India recombinant human growth hormone market had a market share of USD 169.07 million in 2024 and is projected to grow at a CAGR of 8.3% during the forecast period. India's supportive initiatives taken by the government.
• The South Korean recombinant human growth hormone market is projected to witness growth at a CAGR of 5.6% during the forecast period, with a market size of USD 140.89 million in 2024.
• The Australian recombinant human growth hormone market is projected to witness growth at a CAGR of 6.2% during the forecast period, with a market size of USD 73.26 million in 2024.
• The South East Asia recombinant human growth hormone market is projected to witness growth at a CAGR of 7.5% during the forecast period, with a market size of USD 97.21 million in 2024.
• The Rest of Asia Pacific recombinant human growth hormone market is projected to witness growth at a CAGR of 6.3% during the forecast period, with a market size of USD 100.03 million in 2024.

South America Recombinant Human Growth Hormone Market Analysis

According to Cognitive Market Research, the global recombinant human growth hormone market size was estimated at USD 6125.6 Million, out of which the Latin America market has more than 5% of the global revenue with a market size of USD 306.28 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.9% from 2024 to 2031. .

• According to Cognitive Market Research, the Brazil recombinant human growth hormone market size was valued at USD 131.09 million in 2024 and is projected to grow at a CAGR of 4.5% during the forecast period. Recombinant human growth hormone flourished in Brazil due to the high disease burden of rare genetic conditions.
• Argentina's recombinant human growth hormone market had a market share of USD 51.46 million in 2024 and is projected to grow at a CAGR of 4.8% during the forecast period. Argentina's technological advancements augment the demand.
• Colombia recombinant human growth hormone market is projected to witness growth at a CAGR of 3.7% during the forecast period, with a market size of USD 27.26 million in 2024.
• Peru recombinant human growth hormone market is projected to witness growth at a CAGR of 4.1% during the forecast period, with a market size of USD 25.11 million in 2024.
• Chile recombinant human growth hormone market is projected to witness growth at a CAGR of 4.2% during the forecast period, with a market size of USD 22.05 million in 2024.
• The Rest of Latin America's recombinant human growth hormone market is projected to witness growth at a CAGR of 3.0% during the forecast period, with a market size of USD 49.31 million in 2024.

Middle East Recombinant Human Growth Hormone Market Analysis

According to Cognitive Market Research, the global recombinant human growth hormone market size was estimated at USD 6125.6 Million, out of which the Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 122.51 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.2% from 2024 to 2031..

• The GCC Countries recombinant human growth hormone market is projected to witness growth at a CAGR of 5.0% during the forecast period, with a market size of USD 52.44 million in 2024. Recombinant human growth hormone sales flourish due to the presence of major market players.
• The Egypt recombinant human growth hormone market is projected to witness growth at a CAGR of 4.5% during the forecast period, with a market size of USD 12.86 million in 2024.
• The South Africa recombinant human growth hormone market is projected to witness growth at a CAGR of 5.2% during the forecast period, with a market size of USD 19.36 million in 2024. Recombinant human growth hormone sales flourish in South Africa due to technological advancements, increasing demand, and regulatory support.
• The Turkey recombinant human growth hormone market is projected to witness growth at a CAGR of 3.7% during the forecast period, with a market size of USD 10.54 million in 2024.
• The Nigeria recombinant human growth hormone market is projected to witness growth at a CAGR of 3.3% during the forecast period, with a market size of USD 12.86 million in 2024.
• The Rest of MEA recombinant human growth hormone market is projected to witness growth at a CAGR of 3.2% during the forecast period, with a market size of USD 14.46 million in 2024.

Recombinant Human Growth Hormone Market Analysis

Recombinant Human Growth Hormone Market Application Segment Analysis

According to Cognitive Market Research, the dominant category is growth hormone deficiency (GHD) due to the increasing awareness about the benefit of early diagnosis and therapy of hormone deficiency, along with the endeavors of biopharmaceutical firms to introduce innovative therapies, are promoting the adoption of this segment.

The fastest-growing category in the recombinant human growth hormone market is Turner syndrome due to the rising prevalence of Turner syndrome, advancements in recombinant human growth hormone therapies, and increased awareness of early diagnosis and treatment. Enhanced healthcare access, growing research funding, and improving healthcare infrastructure further support market growth by facilitating better management and treatment options for affected individuals.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Recombinant Human Growth Hormone Industry. Request a Free Sample PDF!

Recombinant Human Growth Hormone Market Route of Administration Segment Analysis

According to Cognitive Market Research, the dominant category is intramuscular due to the rising awareness of growth disorders, increasing prevalence of hormonal deficiencies, and advancements in biotechnology. The growing demand for effective treatments for growth hormone deficiencies, coupled with improved delivery methods and regulatory approvals, boosts market growth.

The fastest-growing category in the recombinant human growth hormone market is oral due to rising awareness of growth hormone deficiencies, advancements in oral delivery technologies, and increasing demand for non-injection-based treatments. Additionally, growing applications in pediatric and adult growth disorders, coupled with expanding healthcare access and rising healthcare expenditures, are contributing to market growth.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Recombinant Human Growth Hormone End-User Segment Analysis

Recombinant Human Growth Hormone Market End-User Segment Analysis

According to Cognitive Market Research, the dominant category is hospital pharmacy due to the increasing prevalence of the disorder, higher frequency of hospital stays, and favorable reimbursement procedures are driving the adoption of this segment. Moreover, patients are showing a preference for recombinant and artificial human growth hormone, which is readily available in hospital pharmacies.

The fastest-growing category in the recombinant human growth hormone market is clinics due to the rising prevalence of growth hormone deficiencies, increasing adoption of recombinant human growth hormone for various therapeutic applications, and advancements in biotechnology. Enhanced awareness, improved diagnostic techniques, and growing healthcare infrastructure also contribute to market growth, supporting its use in clinics for treating growth disorders.

• Hospital Pharmacy
• Retail Pharmacy
• Clinics
• Other Pharmacy

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion